Anti-CD2O chimeric monoclonal antibody (Rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease [2]

Konstantinos A. Papadakis, Barry Rosenbloom, Stephan R. Targan

Research output: Contribution to journal › Letter › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-CD2O chimeric monoclonal antibody (Rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease [2]'. Together they form a unique fingerprint.